Clinical Study

Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration

Figure 2

Box plot diagram showing the change in mean aqueous VEGF levels (a) and change in mean aqueous IL-6 levels (b) in patients in group 1. The error bar represents standard deviation.